Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine plus oral vinorelbine in advanced breast cancer
2006-003752-38Phase 2Active
- Sponsor
- Oncology Institute of Bari
- Start
- Jun 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of capecitabine and vinorelbine in breast cancer, sponsored by Oncology Institute of Bari. Primary endpoint: Response rate. Started Jun 2007; status: active.
02
Drugs
capecitabinevinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-003752-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003752-38.